Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Scandinavian Clinical Nutrition, which is engaged in the development and marketing of nutraceuticals or dietary supplements, has extended its collaboration with Vital Life International by adding two products, thin400 and Immulina, to the product portfolio that will be launched and marketed in the UK, Ireland and the Channel Islands.
Subscribe to our email newsletter
Coldizin is scheduled for launch in the third quarter, in time for the ‘cough and cold season’, and Immulina is planned for launch in the fourth quarter. thin400 will be launched as soon as regulatory approval is granted, hopefully during the third quarter, said Scandinavian Clinical Nutrition (SCN).
Under the agreement, Vital Life will be responsible for product marketing and promotion, as well as local regulatory issues, supported by the expertise from SCN.
Danilo Copiz, vice president of sales at SCN, said: “I am pleased that we are taking the next step in our business relationship with Vital Life already. In March we agreed on exclusive rights for the cold product Coldizin, and now Vital Life takes the further step on committing to launch the diet product thin400 and the immune system product Immulina. I have high hopes in Vital Life and their integrated sales and marketing concept, and look forward to seeing the results of their work with our unique product portfolio.”